Showing results (51-60 of 266) with videos related to
Sort By:
Pageof 27
AIDS and Behavior|November 20, 2009
Adherence and its measurement in phase 2/3 microbicide trialsElizabeth E Tolley, Polly F Harrison, Els Goetghebeur, et al.Nucleic Acids Research|August 4, 2006
Genome-wide screening for cis-regulatory variation using a classical diallel crossing schemeRaphaël Kiekens, Annelies Vercauteren, Beatrijs Moerkerke, et al.Analytical Chemistry|March 29, 2017
Model-Based Classification for Digital PCR: Your Umbrella for RainBart K M Jacobs, Els Goetghebeur, Jo Vandesompele, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairmentKarl Herholz, Sarah Westwood, Cathleen Haense, et al.Schizophrenia Bulletin|June 13, 2009
A randomized experimental investigation of reasoning training for people with delusionsKerry Ross, Daniel Freeman, Graham Dunn, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 15, 2004
Autosomal recessive hereditary spastic paraparesis with thin corpus callosum; report of two sistersSteve Vucic, Tanya Lye, Graham Dunn, et al.Psychological Medicine|December 13, 2005
Event attributes and the content of psychotic experiences in first-episode psychosisDavid Raune, Paul Bebbington, Graham Dunn, et al.The British Journal of Psychiatry : the Journal of Mental Science|November 5, 2003
Describing, explaining or predicting mental health care costs: a guide to regression models. Methodological reviewGraham Dunn, Massimo Mirandola, Francesco Amaddeo, et al.Trials|November 23, 2012
The effects of reducing worry in patients with persecutory delusions: study protocol for a randomized controlled trialDaniel Freeman, Graham Dunn, Helen Startup, et al.Clinical Trials (London, England)|September 4, 2013
Integrating biomarker information within trials to evaluate treatment mechanisms and efficacy for personalised medicineGraham Dunn, Richard Emsley, Hanhua Liu, et al.Pageof 27